- $3.51bn
- $3.87bn
- $3.93bn
- 73
- 34
- 84
- 68
Annual income statement for RXO, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,141 | 3,357 | 4,689 | 4,796 | 3,927 |
Cost of Revenue | |||||
Gross Profit | 565 | 615 | 816 | 946 | 725 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,059 | 3,297 | 4,497 | 4,673 | 3,888 |
Operating Profit | 82 | 60 | 192 | 123 | 39 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 84 | 57 | 191 | 119 | 4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 62 | 43 | 150 | 92 | 4 |
Net Income Before Extraordinary Items | |||||
Net Income | 62 | 43 | 150 | 92 | 4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 62 | 43 | 150 | 92 | 4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.641 | 0.531 | 1.33 | 1.44 | 0.268 |
Dividends per Share |